ArticleCureus2026
Antenatal Corticosteroid Exposure in Late Preterm Infants: Clinical Considerations in Diabetic Mothers.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective The objective of this study was to evaluate the association between antenatal corticosteroid (ACS) administration and respiratory and metabolic outcomes among late preterm infants, with a secondary exploratory analysis of infants of diabetic mothers. Methods We performed a retrospective cohort study of 85 neonates born between 33 0/7 and 35 6/7 weeks' gestation at a county hospital to investigate neonatal outcomes according to ACS exposure. Outcomes included respiratory support requirement, duration to room air, hypoglycemia, and hospital length of stay. Results Among 85 infants, 18 (21%) received no ACS, 24 (28%) received one dose, and 43 (51%) received two doses. ACS exposure was not associated with increased hypoglycemia (p = 0.163) or hospital length of stay (p = 0.647). Among infants requiring respiratory support (n = 30), greater ACS exposure was associated with fewer days to room air (Spearman's rho = -0.37, p = 0.044). Conclusions In this small retrospective cohort, ACS exposure was associated with shorter time to room air among late preterm infants requiring respiratory support, without increased risk of hypoglycemia. These findings are exploratory and hypothesis generating, particularly for infants of diabetic mothers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.